Research has shown that both real-time and flash devices enable a person to maintain optimal blood sugar levels. Credit: Peter Stanic from Pixabay.

The National Institute for Health and Care Excellence (Nice) in the UK has recommended the use of real-time continuous glucose monitoring (rtCGM) or intermittently scanned glucose monitoring (isCGM) devices to treat children with type 2 diabetes.

These two technologies have been selected to replace the ‘burdensome’, ‘tiring’ and ‘stressful’ tasks of finger prick testing and insulin therapy.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Designed to offer a continuous stream of real-time data on a smartphone, both devices were already recommended for children with type 1 diabetes.

The recommendation has been made considering the changes made to NICE’s guidelines concerning the diagnosing and managing of type 1 and type 2 diabetes in children and young people.

A discrete sensor is attached to the body to track both current and past glucose levels. It also provides a prediction of the direction in which glucose levels are heading, enabling individuals to administer insulin and stabilise their levels as required.

See Also:

NICE has recommended the utilisation of an isCGM device, commonly referred to as flash monitoring, as a substitute for real-time devices.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Research has revealed that both real-time and flash devices enable a person to maintain optimal blood sugar levels.

NICE Clinical Directorate programme director Dr Judith Richardson said: “Type 2 diabetes in children is the most aggressive form of the disease and recommending new technology is a clear step towards giving children on insulin therapy the ability to manage their own condition in a less invasive way and to live happier and healthier lives.

“Improvements made in managing a child’s diabetes at an early stage can reduce the health impact of the condition later in their lives and the potential impact on the health service.”